Anthem Adds Lilly To Its Real-World Drug Outcomes Research Collaborations
This article was originally published in The Pink Sheet Daily
Executive Summary
The firms are still working to determine specific drugs or disease states to be studied under a five-year agreement. Speeding research dissemination may also be addressed.